FDA Approved: LAPATINIB — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Lupin Pharmaceuticals' original ANDA for Lapatinib, a generic version used in treating breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

ORIG AP for LAPATINIB (LAPATINIB)